VanEck Pharmaceutical ETF
PPH
PPH
51 hedge funds and large institutions have $98.3M invested in VanEck Pharmaceutical ETF in 2016 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 15 increasing their positions, 13 reducing their positions, and 17 closing their positions.
Holders
51
Holders Change
-9
Holders Change %
-15%
% of All Funds
1.28%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
15
Reduced
13
Closed
17
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
JPMorgan Chase & Co
New York
|
$13.2M |
| 2 |
2
Bank of America
Charlotte,
North Carolina
|
$6.43M |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$5.17M |
| 4 |
CC
4
Colrain Capital
Boston,
Massachusetts
|
$2.4M |
| 5 |
5
Morgan Stanley
New York
|
$5.03M |
Top Sellers
| 1 |
1
Goldman Sachs
New York
|
$28.9M |
| 2 |
2
Citigroup
New York
|
$18.4M |
| 3 |
LFM
3
Lumina Fund Management
New York
|
$0 |
| 4 |
VF
4
Virtu Financial
New York
|
$0 |
| 5 |
AL
5
Aspiriant LLC
Los Angeles,
California
|
$0 |
